Leads PA for Abbott’s $8B+ global Nutrition business. Promoted into the role during the infant formula shortage of 2022 due to proven track record of managing crises and complex media and stakeholder relationships. Oversees team of ten and manages multi-million budget. Responsible for all media relations, crisis and issues comms, social media and influencer content, brand and marketing comms, NGO and civic society partnerships, and internal and executive comms. Executes media campaigns and high-visibility partnerships to protect Abbott’s freedom to operate in the U.S. and in emerging markets. Launched multiple digital and media campaigns in support of new product innovations for Abbott’s world-leading pediatric and adult nutrition brands, including the new PROTALITY adult nutrition shake for GLP-1 users, Ensure, Similac, and Pedialyte. Co-leads (with corporate marketing) the company’s brand partnership with Real Madrid as the football (soccer) club’s official health sciences and nutrition partner. Oversees all aspects of branding, joint marketing, earned and owned media, and philanthropic activities through the Real Madrid Foundation. Builds relationships with global NGOs and public health partners to further public health.

Led PA for the world’s largest rapid diagnostics test maker, notably during the COVID-19 pandemic. Responsible for consumer, scientific, crisis, executive, and policy comms. Managed $8MM+ budget. Promoted within the director-grade and awarded Abbott’s highest employee honor (Chairman’s Award) for leadership during the pandemic to burnish Abbott’s reputation and support revenue growth.Devised the media and stakeholder engagement strategies during the pandemic that made at-home testing a multi-billion-dollar industry and put Abbott on the map as a global household name. Launched three COVID rapid tests that became the most profitable and well-known brands in the company’s portfolio (ID NOW, BinaxNOW and Panbio), garnering tens of millions of earned media placements; tens of billions of paid media impressions; and $16B+ in new annual sales (2020-21). Assembled a bench of third-party experts (public health officials, Ivy League epidemiologists and physicians) to advocate for rapid testing and counter pandemic misinformation.Worked with NGOs and Abbott’s global citizenship function to increase access to COVID tests for low- and middle-income countries (LMICs). Enacted communications and coalition strategy for Abbott’s SoToxa roadside drug screening device, helping to 2x revenue in three years. Built relationships with victims’ advocates, policymakers and law enforcement, which led to hundreds of stories in global media and pro-SoToxa legislation and regulatory approvals across North America, Europe and Asia. Directed the post-merger integration of Alere’s PA function into Abbott, following Abbott’s $5.3B acquisition of the world’s largest rapid diagnostics company.

Secured approval from VP of PA to conduct strategic review of Abbott’s PR agencies in LAC. Onboarded new agency network and saved $250k across 12 LAC countries.Executed patient advocacy and media relations initiatives to secure public reimbursement for FreeStyle Libre® system in Canada and biosimilar drugs in LATAM. Placed patient stories and published health economics outcomes research, leading to eventual reimbursement in 6 Canadian provinces and paving way for Abbott’s biosimilar expansion strategy in LATAM. Led PA for Executive Crisis Management teams, creating strategies for public response to persistent bouts of political/social unrest and natural disasters throughout region.Represented PA on Abbott’s Business Area Councils and Executive Crisis Management Teams in Latin American and Canada. Led strategy and public response to natural disasters and persistent bouts of political and social unrest throughout the region.

Supported storytelling efforts for earnings and finance; litigation; citizenship and sustainability; and policy comms. Placed hundreds of stories in global top-tier media centered on workplace and financial leadership, science and innovation, and strength of management.Partnered with trade associations (AdvaMed, ACT) to shape public policy coverage on trade, immigration, the medical device tax, and the Affordable Care Act.Implemented Abbott’s newly-launched corporate brand identity (Life. To the Fullest) and developed brand architecture and expression guidelines that were rolled out worldwide across the company’s digital and product offerings.

Helped develop the world’s first patented decision-support system for information warfighters (psychological and information operations), marketers, and communicators. Implemented the system in government and private sector clients.Led private sector accounts including Abbott, Booz Allen Hamilton, Dell, Dow Corning, HP, Intel, Royal Dutch Shell, SAP, and VMware. Supported public sector engagements at the U.S. Department of Defense.

Supported accounts in the healthcare, sports, consumer, and entertainment industries while attending graduate school.

Authored op-eds on international and domestic policy, popular culture and social issues.

Supported committee, communications and legislative work on Appropriations, Energy and Water, Judiciary, Intelligence, and Transportation and Infrastructure.

Developed research tools to identify and profile U.S. and international companies with fiduciary exposure to terrorist-sponsoring states. Prepared reports on pension liabilities, shell companies and geo-political risk that were sold to corporations, investment managers, and fixed income institutional clients.